Javascript must be enabled to continue!
Quantitative Assessment of Rectal Dose–Volume Histogram (DVH) Constraint Deviations in Image-Guided Hypofractionated Prostate Radiotherapy
View through CrossRef
Introduction: We aimed to investigate changes in rectal dose during the treatment course for prostate cancer patients treated with hypofractionated radiotherapy with daily image-guidance.
Methodology: This study included 20 prostate cancer patients treated with VMAT hypofractionated RT (60 Gy/20 Fr). IMRT- VMAT planning was performed using simulation CT images. Four patients were excluded due to inability to plan with CBCT images. Patient set-up correction shifts was used as a mesure of the daily Inter-fraction motion. The rectum was outlined on both the original treatment plan and the subsequent daily CBCT images by the same investigator. Rectal doses from the daily CT images were recalculated and compared to the original treatment plan, applying clinical acceptance criteria (V60 < 3%, V52.8 < 30%, V48.6 < 50%, and V40.8 < 60%). Rectal volume variations (V0-VX) and dose constraints were assessed for DVH compliance using post-hoc analysis and repeated measures ANOVA. Linear regression was used to evaluate the relationship between mean rectal dose constraints and rectal volume variations across all patients.
Results: Data from 16 patients with 240 daily CBCT sets were analyzed. Mean Rectal volume variation was -0.54 [- 69,76-67cc] (Figure1-A). The mean values for V60, V52.8, V48.6, and V40.8 were 2.58[0-6.15], 5.45[0-10.98], 8.47 [1.48-18.01], 11.73[4.41-23.58] and 18.69[8.69-34,91], respectively (Figure1-B). Repeated measures ANOVA analysis revealed that 7,5% (18/240), 93,75% (225/240), 14,5% (35/240), 1,25% (3/240) and 1,25% (3/240) of the subsequent treatment dose distributions did not meet our criterion of V60 < 3%, V57 <15 %, V52.8 < 30%, V48.6 < 50% and V40.8 < 60%, respectively.
The inter-fractional rectal volume variation was non-significant. (Friedman-test p=0,97). However, the variation of rectal dose constraints was significative for V57 (p=0.003), V52,8 (p=0.01) and V48.6 (p<0.0001) but not for V60 (p=0.058). The linear regression model showed a negative coefficient estimate between the mean rectal volume variation and the V57 (p<0.001) and V48.6 (p<0.001). Furthermore, a variation in rectal volume beyond 57.6 cc was significantly associated with violations of all rectal dose constraints (p < 0.001) (Table 1).The correlation between the variation in mean rectal volume and the variation in dose constraints was most significant during the fourth week of treatment (p = 0.015).
Conclusion: Image guided radiotherapy enabled compliance with rectal dose constraints in over 80% of treatment courses, meeting our clinical acceptance criteria. However, the V57 Gy constraint was not met in 93% of cases, de- spite moderate inter-fractional rectal volume variations. A toxicity evaluation is needed to assess the clinical significance of this constraint.
Title: Quantitative Assessment of Rectal Dose–Volume Histogram (DVH) Constraint Deviations in Image-Guided Hypofractionated Prostate Radiotherapy
Description:
Introduction: We aimed to investigate changes in rectal dose during the treatment course for prostate cancer patients treated with hypofractionated radiotherapy with daily image-guidance.
Methodology: This study included 20 prostate cancer patients treated with VMAT hypofractionated RT (60 Gy/20 Fr).
IMRT- VMAT planning was performed using simulation CT images.
Four patients were excluded due to inability to plan with CBCT images.
Patient set-up correction shifts was used as a mesure of the daily Inter-fraction motion.
The rectum was outlined on both the original treatment plan and the subsequent daily CBCT images by the same investigator.
Rectal doses from the daily CT images were recalculated and compared to the original treatment plan, applying clinical acceptance criteria (V60 < 3%, V52.
8 < 30%, V48.
6 < 50%, and V40.
8 < 60%).
Rectal volume variations (V0-VX) and dose constraints were assessed for DVH compliance using post-hoc analysis and repeated measures ANOVA.
Linear regression was used to evaluate the relationship between mean rectal dose constraints and rectal volume variations across all patients.
Results: Data from 16 patients with 240 daily CBCT sets were analyzed.
Mean Rectal volume variation was -0.
54 [- 69,76-67cc] (Figure1-A).
The mean values for V60, V52.
8, V48.
6, and V40.
8 were 2.
58[0-6.
15], 5.
45[0-10.
98], 8.
47 [1.
48-18.
01], 11.
73[4.
41-23.
58] and 18.
69[8.
69-34,91], respectively (Figure1-B).
Repeated measures ANOVA analysis revealed that 7,5% (18/240), 93,75% (225/240), 14,5% (35/240), 1,25% (3/240) and 1,25% (3/240) of the subsequent treatment dose distributions did not meet our criterion of V60 < 3%, V57 <15 %, V52.
8 < 30%, V48.
6 < 50% and V40.
8 < 60%, respectively.
The inter-fractional rectal volume variation was non-significant.
(Friedman-test p=0,97).
However, the variation of rectal dose constraints was significative for V57 (p=0.
003), V52,8 (p=0.
01) and V48.
6 (p<0.
0001) but not for V60 (p=0.
058).
The linear regression model showed a negative coefficient estimate between the mean rectal volume variation and the V57 (p<0.
001) and V48.
6 (p<0.
001).
Furthermore, a variation in rectal volume beyond 57.
6 cc was significantly associated with violations of all rectal dose constraints (p < 0.
001) (Table 1).
The correlation between the variation in mean rectal volume and the variation in dose constraints was most significant during the fourth week of treatment (p = 0.
015).
Conclusion: Image guided radiotherapy enabled compliance with rectal dose constraints in over 80% of treatment courses, meeting our clinical acceptance criteria.
However, the V57 Gy constraint was not met in 93% of cases, de- spite moderate inter-fractional rectal volume variations.
A toxicity evaluation is needed to assess the clinical significance of this constraint.
Related Results
Sequelae after multimodal treatment of rectal cancer
Sequelae after multimodal treatment of rectal cancer
<p dir="ltr">In recent decades, rectal cancer treatment has shifted from traditional surgical resection to include additional modalities such as radiotherapy and chemotherapy...
Sequelae after multimodal treatment of rectal cancer
Sequelae after multimodal treatment of rectal cancer
<p dir="ltr">In recent decades, rectal cancer treatment has shifted from traditional surgical resection to include additional modalities such as radiotherapy and chemotherapy...
Clinical outcomes of hypofractionated radiotherapy (5x5 Gy) with a simultaneous integrated boost (5x6 Gy) in locally advanced rectal cancer.
Clinical outcomes of hypofractionated radiotherapy (5x5 Gy) with a simultaneous integrated boost (5x6 Gy) in locally advanced rectal cancer.
60
Background:
Hypofractionated RT (5x5 Gy) with or without subsequent chemotherapy is a standard of care used at the National Institu...
The 20-core prostate biopsy as an initial strategy: impact on the detection of prostatic cancer
The 20-core prostate biopsy as an initial strategy: impact on the detection of prostatic cancer
Introduction: To increase the detection rate of prostate cancer inrecent years, we examined the increase in the number of corestaken at initial prostate biopsy. We hypothesized tha...
Radiomic and Dosiomic Features for the Prediction of Radiation Pneumonitis Across Esophageal Cancer and Lung Cancer
Radiomic and Dosiomic Features for the Prediction of Radiation Pneumonitis Across Esophageal Cancer and Lung Cancer
PurposeThe aim was to investigate the advantages of dosiomic and radiomic features over traditional dose-volume histogram (DVH) features for predicting the development of radiation...
Biological dosiomic features for the prediction of radiation pneumonitis in esophageal cancer patients
Biological dosiomic features for the prediction of radiation pneumonitis in esophageal cancer patients
Abstract
Objective
The purpose of this study was to develop a model using dose volume histogram (DVH) and dosiomic features to predict the risk of r...
IMRT: Improvement in treatment planning efficiency using NTCP calculation independent of the dose‐volume‐histogram
IMRT: Improvement in treatment planning efficiency using NTCP calculation independent of the dose‐volume‐histogram
The normal tissue complication probability (NTCP) is a predictor of radiobiological effect for organs at risk (OAR). The calculation of the NTCP is based on the dose‐volume‐histogr...
Correlation between Prostate-Specific Antigen Levels and Prostate Imaging Reporting and Data System score: A Retrospective Study
Correlation between Prostate-Specific Antigen Levels and Prostate Imaging Reporting and Data System score: A Retrospective Study
Introduction: Prostate cancer is a prevalent and potentially lethal malignancy affecting men worldwide. To enhance early detection and accurate risk stratification, various diagnos...

